Print

Please select the PCN:

Additional Polypharmacy Indicators

 

Indicator IP1.85

The average number of unique medicines prescribed per patient - for patients ≥85 years old (i-chart)

Sorry, chart data coming soon

 

More information about this indicator

Definition: The average number of unique medicines prescribed per patient - for patients ≥85 years old

Numerator: Total number of unique medicines prescribed for patients,aged 85 and over, from BNF chapters 1 to 4 & 6 to 10

Denominator: Total number of patients, aged 85 and over, prescribed one or more medicines from BNF chapters 1 to 4 & 6 to 10

Please follow this link for a detailed technical specification ( on page 8 of this publication prepared by NHS BSA)

Data for this indicator has been sourced from the ePACT2 data warehouse. Click here to login to ePACT2.

 

Indicator IP2.85

Percentage of patients prescribed 8≥ unique medicines and ≥85 years old (p-chart)

Sorry, chart data coming soon

 

More information about this indicator

Definition: Percentage of patients prescribed 8≥ unique medicines and ≥85 years old

Numerator: Number of patients, aged 85 and over, prescribed 8 or more unique medicines

Denominator: Total number of patients, aged 85 and over, prescribed one or more medicines from BNF chapters 1 to 4 & 6 to 10

Please follow this link for a detailed technical specification ( on page 9 of this publication prepared by NHS BSA)

Data for this indicator has been sourced from the ePACT2 data warehouse. Click here to login to ePACT2.

 

Indicator IP3.6

Percentage of patients with an anticholinergic burden score ≥9 (p-chart)

Sorry, chart data coming soon

 

More information about this indicator

Definition: Percentage of patients with an anticholinergic burden score ≥9

Numerator: Number of patients prescribed one or more anticholinergic medicines with a combined anticholinergic burden (ACB) score of 9 or greater

Denominator: Total number of patients prescribed one or more medicines from BNF chapters 1 to 4 & 6 to 10

Please follow this link for a detailed technical specification ( on page 10 of this publication prepared by NHS BSA)

Data for this indicator has been sourced from the ePACT2 data warehouse. Click here to login to ePACT2.

 

Indicator IP4

Percentage of patients prescribed medicines likely to cause Acute Kidney Injury DAMN (Diuretics/ACI&ARBs/Metformin/NSAIDS) drugs (p-chart)

Sorry, chart data coming soon

 

More information about this indicator

Definition: Percentage of patients prescribed two or more unique medicines likely to cause kidney injury (DAMN medicines)

Numerator: Number of patients prescribed 2 or more unique medicines likely to induce, exacerbate or complicate acute kidney injury (DAMN medicines)

Denominator: Number of patients prescribed 1 or more unique medicines likely to induce, exacerbate or complicate acute kidney injury (DAMN medicines)

Please follow this link for a detailed technical specification ( on page 14 and 15 of this publication prepared by NHS BSA)

Data for this indicator has been sourced from the ePACT2 data warehouse. Click here to login to ePACT2.

 

Indicator IP5

Percentage of patients prescribed a NSAID and ≥ 1 other unique medicines likely to cause kidney injury (DAMN drugs) (p-chart)

Sorry, chart data coming soon

 

More information about this indicator

Definition: Percentage of patients prescribed a NSAID and one or more other unique medicines likely to cause kidney injury (DAMN medicines)

Numerator: Number of patients prescribed a NSAID and one or more other unique medicines likely to cause kidney injury (DAMN medicines)

Denominator: Number of patients prescribed 1 or more unique medicines likely to induce, exacerbate or complicate acute kidney injury (DAMN medicines)

Please follow this link for a detailed technical specification ( on page 16 and 17 of this publication prepared by NHS BSA)

Data for this indicator has been sourced from the ePACT2 data warehouse. Click here to login to ePACT2.

 

 

Gastrointestinal Bleed Risk

 

Indicator S1

GIB01:[Increased risk of hospital admission] Prescribed NSAID without gastro-protection (i-chart)

This indicator is not available at PCN level. Please visit CCG, STP or AHSN pages to view data relating to this indicator.

 

More information about this indicator

Title: GIB01 Patients aged 65 or over currently prescribed a non-steroidal anti-inflammatory drug (NSAID) without a gastro protective medicine and therefore potentially at increased risk of admission to hospital with a GI bleed.

Definition: Number of patients aged 65 or over in the month of prescription currently prescribed a non-steroidal anti-inflammatory drug (NSAID) without a gastro protective medicine per 10,000 patients currently prescribed a NSAID (with or without a gastro-protective)

Numerator: Patients aged 65 or over in the prescription month prescribed a nonsteroidal anti-inflammatory drug (NSAID) without a gastro protective medicine

Denominator: Patients aged 65 or over in the prescription month prescribed a nonsteroidal anti-inflammatory drug (NSAID) with or without a gastro-protective medicine).

Methodology: Numerator divided by denominator, presented per 10,000 patients.

Purpose: The purpose of the indicator is to quantify the number of patients who are prescribed a non-steroidal anti-inflammatory drug (NSAID) without a gastro-protective medicine, and therefore potentially having an increased risk of a GI bleed, presented as a proportion (per 10,000) of patients taking a NSAID with or without a gastro protective medicine.

Rationale: A non-steroidal anti-inflammatory drug (NSAID) prescribed without a gastro-protective medicine may increase the risk of a gastro-intestinal bleed.

Reporting Level: Quarterly aggregate results at National, Regional and CCG level>

A detailed technical specification for this indicator is available from page 15 - 17 of this publication (prepared by NHS BSA)

Data for this indicator has been sourced from the ePACT2 data warehouse. Click here to login to ePACT2.

 

Indicator S4

GIB04:[Increased risk of hospital admission] Prescribed aspirin + anti-platelet without gastro-protection (i-chart)

This indicator is not available at PCN level. Please visit CCG, STP or AHSN pages to view data relating to this indicator.

 

More information about this indicator

Title: GIB04 Patients 18 years old or over prescribed aspirin and another anti-platelet and not concurrently prescribed a gastro-protective medicine and therefore potentially at increased risk of admission to hospital with a GI bleed.

Definition: Number of patients aged 18 or over in the month of prescription currently prescribed aspirin and another anti-platelet and not concurrently prescribed a gastro-protective medicine per 10,000 patients currently prescribed aspirin and an anti-platelet (with or without a gastro-protective medicine).

Numerator: Patients 18 years old or over prescribed aspirin and another anti-platelet and not concurrently prescribed a gastro-protective medicine. See admission rate indicator (denominator) for specifications of patient age group, non-steroidal anti-inflammatory drugs (NSAIDs) and gastro- protective medicines.

Denominator: Patients aged 18 or over in the prescription month prescribed aspirin and another anti-platelet (with or without a gastro-protective medicine). See admission rate indicator denominator) for specifications of patient age group and non-steroidal anti-inflammatory drugs (NSAIDs).

Methodology: Numerator divided by denominator, presented per 10,000 patients.

Purpose: The purpose of the indicator is to quantify the number of patients taking aspirin with another anti-platelet and not concurrently taking a gastroprotective medicine, and therefore potentially have an increased risk of a GI bleed, presented as a proportion (per 10,000) of patients taking aspirin with another anti-platelet (i.e. with or without a gastro-protective medicine).

Rationale: Aspirin and another anti-platelet prescribed together without a gastroprotective medicine may increase the risk of a gastro-intestinal bleed.

Reporting Level: Quarterly aggregate results at National, Regional and CCG level>

A detailed technical specification for this indicator is available from page 15 - 17 of this publication (prepared by NHS BSA)

Data for this indicator has been sourced from the ePACT2 data warehouse. Click here to login to ePACT2.

 

Indicator S5

GIBCI:[Increased risk of hospital admission] Composite increased risk indicator - gastro-intestinal bleed (i-chart)

This indicator is not available at PCN level. Please visit CCG, STP or AHSN pages to view data relating to this indicator.

 

More information about this indicator

Title: The Composite Gastro Intestinal Bleeds comprising of unique patients from indicators 1 to 4

Definition: Composite Gastro Intestinal Bleeds comprising of unique patients from indicators GIB01 to GIB04

Numerator: Unique admissions from numerators of all four gastro-intestinal bleed indicators.

Denominator: Unique patients from denominators of all four gastro-intestinal bleed indicators.

Methodology: Numerator divided by denominator, presented as admissions per 10,000 patients at increased risk.

Reporting Level: Rolling 12 months aggregate results (most recent four quarters) at National, Regional and CCG level

Purpose: See GIB01, GIB02, GIB03 and GIB04

A detailed technical specification for this indicator is available from page 15 - 17 of this publication (prepared by NHS BSA)

Data for this indicator has been sourced from the ePACT2 data warehouse. Click here to login to ePACT2.

 

NB: Low volume figures have not been redacted and therefore individual patients may be identifiable. Please take care when disseminating data and contact your Caldicott Guardian for further guidance.

Hits: 101